SCHEMBL26207664

SCHEMBL26207664

CC(C)N1CCC[C@H]1CC(=O)N1CCCC1CS(N)(=O)=O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 3/20 0.36
▸ RAB9A P51151 3/20 0.36
▸ ALDH1A1 P00352 3/20 0.35
▸ XPNPEP1 Q9NQW7 1/20 0.35
▸ KDM4E B2RXH2 2/20 0.34
▸ POLB P06746 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ DPP4 P27487 2/20 0.33
▸ DPP8 Q6V1X1 2/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ DPP9 Q86TI2 1/20 0.33
▸ DPP7 Q9UHL4 1/20 0.33
▸ CHRM3 P20309 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ ACE P12821 3/20 0.33
▸ F2 P00734 1/20 0.33
▸ REN P00797 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ LTA4H P09960 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26997636 0.88 NPC1 (0.37) NPC1RAB9AALDH1A1XPNPEP1KDM4E
SCHEMBL26724183 0.88 ALDH1A1 (0.44) NPC1RAB9AALDH1A1KDM4EPOLB
SCHEMBL20744162 0.83 CHRM3 (0.34) XPNPEP1CHRM3
SCHEMBL26734026 0.81 SMN1; SMN2 (0.42) NPC1RAB9AALDH1A1XPNPEP1POLB
SCHEMBL26213423 0.79 NPC1 (0.44) NPC1RAB9AALDH1A1KDM4EPOLB
SCHEMBL20744470 0.78 PSEN1 (0.33) ALDH1A1CHRM3KMT2A
SCHEMBL26207734 0.77 CHRM3 (0.32) ALDH1A1DPP4DPP8DPP9DPP7
SCHEMBL26207700 0.77 ACE (0.50) RAB9AKDM4EACEF2REN
SCHEMBL26724187 0.77 ACE (0.38) RAB9AKDM4EPOLBL3MBTL1ACE
SCHEMBL26724185 0.77 ACE (0.38) RAB9AKDM4EPOLBL3MBTL1ACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230357158-A1 QUINOLINE cGAS ANTAGONIST COMPOUNDS THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM 2023-11-09 — — US disclosed
WO-2023168367-A1 QUINOLINE cGAS ANTAGONIST COMPOUNDS IMMUNESENSOR THERAPEUTICS, INC. (US) 2023-09-07 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230357158-A1 QUINOLINE cGAS ANTAGONIST COMPOUNDS CGAS, GLS2, GLS NPC1 667/4885RAB9A 2346/4885ALDH1A1 4236/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback